Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01635348 · ClinicalTrials.gov registry record · Phase 2

Thinking, Walking Outcomes by Type of Exercise

A Phase 2 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 2
Development phase
22
Enrollment target

NCT01635348: Completed Phase 2 study, sponsored by University of Pittsburgh.

NCT01635348 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 22 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01635348, a Phase 2 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 2
Development phase
22 participants
Enrollment target

Study Summary

The purpose of this research study is to compare two different exercise treatments for walking problems in older adults. The investigators want to determine if participation in the exercise programs will improve walking and thinking abilities.

Primary Outcome

The outcome measure is a cognitive task such as working memory, visual-spatial orientation, and set shifting measures of cognitive function performed while walking over an oval track.

Interventions

  • BEHAVIORAL motor skill gait exercise
  • BEHAVIORAL aerobic gait intervention

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2011-01
Est. Completion 2013-10
Phase Phase 2
University of Pittsburgh

1,238 total trials

What the finished NCT01635348 record still lists

NCT01635348 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which motor skill gait exercise is the first listed.

NCT01635348 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01635348 about?

NCT01635348 is a clinical study titled "Thinking, Walking Outcomes by Type of Exercise". The purpose of this research study is to compare two different exercise treatments for walking problems in older adults. The investigators want to determine if participation in the exercise programs will improve walking and thinking abilities.

What is the current status of trial NCT01635348?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2011-01. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01635348?

The interventions under investigation include: motor skill gait exercise (BEHAVIORAL), aerobic gait intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01635348?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01635348's enrollment target sits among peer trials

22 1790th of 2000 higher than 207 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01635348, the US trial registry maintained by the National Library of Medicine. NCT01635348 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.